AMENDMENT NO. 2 TO RIGHTS AGREEMENTRights Agreement • August 30th, 2019 • Catalyst Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 30th, 2019 Company Industry JurisdictionThis AMENDMENT NO. 2 TO RIGHTS AGREEMENT (the “Amendment”), dated as of August 28, 2019 (the “Effective Date”), amends that certain Rights Agreement, dated as of September 20, 2011, as previously amended by that certain Amendment No. 1 to Rights Agreement, dated as of September 19, 2016 (collectively, the “Rights Agreement”) between Catalyst Pharmaceuticals, Inc. (f/k/a Catalyst Pharmaceutical Partners, Inc.), a Delaware corporation (the “Company”) and Continental Stock Transfer and Trust Company (the “Rights Agent”). Capitalized terms used, but not otherwise defined, herein shall have the respective meanings ascribed to such terms in the Rights Agreement.